Organization
Iview Therapeutics
4 clinical trials
Clinical trial
A Double-Masked, Placebo-Controlled, Randomized, Phase II Clinical Trial To Assess The Efficacy Of IVIEW-1201 In The Treatment Of Acute Adenoviral ConjunctivitisStatus: Completed, Estimated PCD: 2023-12-31
Clinical trial
A Phase II, Multi-Center, Randomized, Parallel Controlled Study to Evaluate the Clinical Efficacy and Safety of IVIEW 1201 Compared to Ofloxacin Eye Drops in the Treatment of Acute Bacterial ConjunctivitisStatus: Completed, Estimated PCD: 2023-09-13
Clinical trial
Phase 1/2a, Proof-of-Concept, Multicenter, Parallel, Vehicle-Controlled, Double-Masked, Randomized Study Evaluating the Safety, Tolerability, and Efficacy of IVW-1001 Ophthalmic Eyelid Wipe in Subjects With Dry Eye DiseaseStatus: Not yet recruiting, Estimated PCD: 2025-07-01
Clinical trial
A Phase II, Multi-center, Randomized, Masked, Parallel-Control Study to Evaluate the Clinical Efficacy and Safety of IVIEW-1201 (1.0% PVP-Iodine) Gel Forming Ophthalmic Solution in the Treatment of Fungal KeratitisStatus: Not yet recruiting, Estimated PCD: 2026-12-01